Home | Symbol Index | About |
Fri, 7 Jul 2006 7:54:00 PDT
AMARILLO, TX (MARKET WIRE) Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced that it submitted an Investigational New Drug (IND) Application to the FDA to begin a study of orally delivered interferon alpha in 60 patients with idiopathic pulmonary fibrosis (IPF). These IPF patients will be enrolled from approximately six clinical sites in the US. The patients will be given interferon or placebo for four weeks to assess
Trackbacks
A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Amarillo Biosciences, Inc. : Amarillo Biosciences Submits Investigational New Drug Application to Test Oral Interferon in Idiopathic Pulmonary Fibrosis.
- No trackbacks have been detected.
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.